What are the major opportunities in the Gastrointestinal Over The Counter OTC Drugs market? What are the strategies for the Gastrointestinal Over The Counter OTC Drugs market?

For detailed insights on the major opportunities and strategies in the Gastrointestinal Over The Counter OTC Drugs market, Read More

How does the Gastrointestinal Over The Counter OTC Drugs market relate to the overall economy and other similar markets?

For detailed insights on Gastrointestinal Over The Counter OTC Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gastrointestinal Over The Counter OTC Drugs market growth? SWOT analysis of the Gastrointestinal Over The Counter OTC Drugs market.

For detailed insights on the key dynamics influencing the Gastrointestinal Over The Counter OTC Drugs market growth and SWOT analysis of the Gastrointestinal Over The Counter OTC Drugs industry, Read More

Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Gastrointestinal Over-The-Counter (OTC) Drugs Global Market Report 2025

Name: Gastrointestinal Over-The-Counter (OTC) Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products), By Formulation (Tablets, Capsules, Liquids, Other Formulations), By Indications (Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications), By Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Clinics, Home Healthcare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Gastrointestinal over-the-counter (OTC) drugs are medications available without a prescription to prevent or treat common digestive system problems. They offer fast and easy relief for issues such as indigestion and irregular bowel movements to effectively manage mild to moderate digestive discomfort and support overall digestive wellness safely and conveniently.

The main products of gastrointestinal OTC drugs are antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids are medications that neutralize stomach acid to relieve heartburn and indigestion. It is available in various formulations, such as tablets, capsules, liquids, and others, for several indications, including heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and others. It is distributed through various distribution channels, such as direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others, and used by several key end-users, including hospitals, clinics, home healthcare, and others.

Gastrointestinal Over-The-Counter (OTC) Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Size 2025 And Growth Rate?

The gastrointestinal over-the-counter (otc) drugs market size has grown strongly in recent years. It will grow from $45.73 billion in 2024 to $49.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rising prevalence of gastrointestinal disorders, increasing consumer preference for self-medication, rise in availability of OTC proton pump inhibitors, increasing awareness of digestive health, and rise in geriatric population prone to GI issues.

What Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Forecast?

The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $67.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing demand for rapid symptom relief solutions, increasing penetration of e-commerce pharmacies, expanding availability of combination OTC therapies, rising focus on gut microbiome health, and increasing marketing and awareness campaigns by key players. Major trends in the forecast period include advancement in the formulation of fast-acting antacids, innovation in probiotic-based OTC products, integration of herbal ingredients in digestive remedies, advancement in packaging for dose accuracy and portability, and innovation in sustained-release gastrointestinal therapies.

Book your 30 minutes free consultation with our research experts

How Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmented?

The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented –

1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products

2) By Formulation: Tablets, Capsules, Liquids, Other Formulations

3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications

4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids

2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives

3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, probiotics, Electrolyte Solutions

4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements

5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal

What Is Driving The Gastrointestinal Over-The-Counter (OTC) Drugs Market? The Increasing Prevalence Of Digestive Disorders Is Fueling The Growth Of The Market Due To Growing Digestive Health Concerns

The increasing prevalence of digestive disorders is expected to propel the growth of the gastrointestinal OTC drugs market going forward. Digestive disorders refer to a range of conditions that affect the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in digestive disorders is mainly due to higher intake of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs ease digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and enhancing gut health. They provide fast, convenient relief from common issues like acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of digestive disorders is driving the growth of the gastrointestinal OTC drugs market.

Who Are The Major Players In The Global Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Major companies operating in the gastrointestinal over-the-counter (OTC) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

What Are The Key Trends Of The Global Gastrointestinal Over-The-Counter (OTC) Drugs Market? Advancements In OTC Gastrointestinal Drugs For Long-Lasting Acid Relief

Major companies operating in the gastrointestinal OTC drugs market are focusing on developing advanced products, such as OTC proton pump inhibitors, to provide effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of medications available without a prescription that reduce the production of stomach acid. They are commonly used to treat conditions such as frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, making it the first OTC PPI in Japan containing the same active ingredient and dosage as the prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market? Glenmark Pharmaceuticals Acquired Wockhardt To Strengthen Its U.S. Gastrointestinal OTC Portfolio

In June 2022, Glenmark Pharmaceuticals Ltd., a US-based pharmaceutical company, acquired specific OTC drugs from Wockhardt Ltd. for an undisclosed sum. The acquisition aims to enhance Glenmark’s OTC portfolio in the U.S., particularly in the gastrointestinal category. Wockhardt Limited is a US-based pharmaceutical company that manufactures gastrointestinal OTC drugs.

What Is The Regional Outlook For The Global Gastrointestinal Over-The-Counter (OTC) Drugs Market?

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal over-the-counter (OTC) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gastrointestinal Over-The-Counter (OTC) Drugs Industry?

The gastrointestinal OTC drugs market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal OTC drugs market statistics, including the gastrointestinal OTC drugs industry global market size, regional shares, competitors with the gastrointestinal OTC drugs market share, detailed gastrointestinal OTC drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the gastrointestinal OTC drugs industry. This gastrointestinal OTC drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Gastrointestinal Over The Counter OTC Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$49.59 billion
Revenue Forecast In 2034	$67.88 billion
Growth Rate	CAGR of 8.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented – 1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products 2) By Formulation: Tablets, Capsules, Liquids, Other Formulations 3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications 4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels 5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users Subsegments: 1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids 2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives 3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions 4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements 5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Characteristics

3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends And Strategies

4. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Rate Analysis

5.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Total Addressable Market (TAM)

6. Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

6.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antacid

Laxatives

Anti-Diarrheal

Anti-Emetics

Other Products

6.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Liquids

Other Formulations

6.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Heartburn

Diarrhoea

Constipation

Gastroesophageal Reflux Disease (GERD)

Nausea

Vomiting

Motion Sickness

Other Indications

6.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Tender

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Other Distribution Channels

6.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Home Healthcare

Other End-Users

6.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Proton Pump Inhibitors (PPIs)

H2-Receptor Antagonists

Calcium Carbonate

Magnesium Hydroxide

Sodium Bicarbonate

Combination Antacids

6.7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bulk-Forming Laxatives

Stimulant Laxatives

Osmotic Laxatives

Stool Softeners

Lubricant Laxatives

6.8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Loperamide

Bismuth Subsalicylate

Probiotics

Electrolyte Solutions

6.9. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antihistamines

Bismuth Subsalicylate

Phosphorated Carbohydrate Solution

Ginger Supplements

6.10. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Digestive Enzymes

Antispasmodics

Simethicone

Herbal Remedies

Activated Charcoal

7. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regional And Country Analysis

7.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market

8.1. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Over-The-Counter (OTC) Drugs Market

9.1. China Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

9.2. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Over-The-Counter (OTC) Drugs Market

10.1. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market

11.1. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

11.2. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market

12.1. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market

13.1. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market

14.1. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

14.2. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

15.1. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

15.2. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market

16.1. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market

17.1. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Over-The-Counter (OTC) Drugs Market

18.1. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market

19.1. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market

20.1. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

21.1. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

21.2. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market

22.1. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market

23.1. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

23.2. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market

24.1. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

24.2. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market

25.1. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

25.2. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market

26.1. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

26.2. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market

27.1. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market

28.1. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

28.2. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market

29.1. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

29.2. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

30.1. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape

30.2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Over-The-Counter (OTC) Drugs Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi S.A.

31.3. AstraZeneca plc

31.4. Abbott Laboratories

31.5. GlaxoSmithKline plc

31.6. Takeda Pharmaceutical Company Limited

31.7. Teva Pharmaceutical Industries Ltd.

31.8. Reckitt Benckiser Group plc

31.9. Boehringer Ingelheim GmbH

31.10. Haleon plc

31.11. Sandoz AG

31.12. Bausch Health Companies Inc.

31.13. Sun Pharmaceutical Industries Ltd.

31.14. Perrigo Company plc

31.15. Dr. Reddy's Laboratories Ltd.

32. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

34. Recent Developments In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

35. Gastrointestinal Over-The-Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

35.1 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: Procter & Gamble Co. Financial Performance

Table 83: Johnson & Johnson Financial Performance

Table 84: Merck & Co. Inc. Financial Performance

Table 85: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Procter & Gamble Co. Financial Performance

Figure 83: Johnson & Johnson Financial Performance

Figure 84: Merck & Co. Inc. Financial Performance

Figure 85: Bayer AG Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Digestive Health Supplements Global Market Report 2025 – By Product (Prebiotics, Probiotics, Enzymes, Fulvic Acid, Other Product), By Form (Capsules, Tablets, Powders, Liquids, Other Form), By Distribution Channel (Super...

Dermatology OTC Medications Global Market Report 2025 – By Type (Tablets And Capsules, Oils Gels, Creams And Ointments, Other Types), By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover,...

Gastric Cancer Drugs Global Market Report 2025 – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Specialty Centers) – Impact of Tariff ...

Otic Drugs Global Market Report 2025 – By Drug Class (Cerumenolytics, Otic Anesthetics, Otic Anti-Infectives, Otic Steroids, Other Drug Class), By Indication (Otitis, Middle Ear Infections, Other Indication), By Route of...

Colorectal Cancer Drugs Global Market Report 2025 – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL...

OTC Drug And Dietary Supplement Global Market Report 2025 – By Category (Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Ca...

Gastroparesis Drugs Global Market Report 2025 – By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), By Disease...

Frequently Asked Questions

What is the definition of the Gastrointestinal Over The Counter OTC Drugs market?

How will the Gastrointestinal Over The Counter OTC Drugs market drivers and restraints affect the market dynamics? What forces will shape the Gastrointestinal Over The Counter OTC Drugs industry going forward?

The Gastrointestinal Over The Counter OTC Drugs market major growth driver - The Increasing Prevalence Of Digestive Disorders Is Fueling The Growth Of The Market Due To Growing Digestive Health Concerns. For further insights on the Gastrointestinal Over The Counter OTC Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Gastrointestinal Over The Counter OTC Drugs market?

The Gastrointestinal Over The Counter OTC Drugs market size has grown strongly in recent years. The gastrointestinal over-the-counter (otc) drugs market size has grown strongly in recent years. It will grow from $45.73 billion in 2024 to $49.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rising prevalence of gastrointestinal disorders, increasing consumer preference for self-medication, rise in availability of OTC proton pump inhibitors, increasing awareness of digestive health, and rise in geriatric population prone to GI issues. The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $67.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing demand for rapid symptom relief solutions, increasing penetration of e-commerce pharmacies, expanding availability of combination OTC therapies, rising focus on gut microbiome health, and increasing marketing and awareness campaigns by key players. Major trends in the forecast period include advancement in the formulation of fast-acting antacids, innovation in probiotic-based OTC products, integration of herbal ingredients in digestive remedies, advancement in packaging for dose accuracy and portability, and innovation in sustained-release gastrointestinal therapies. For further insights on the Gastrointestinal Over The Counter OTC Drugs market, request a sample here

How is the Gastrointestinal Over The Counter OTC Drugs market segmented?

The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented –
1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users

Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal For further insights on the Gastrointestinal Over The Counter OTC Drugs market, request a sample here

Which region has the largest share of the Gastrointestinal Over The Counter OTC Drugs market? What are the other regions covered in the report?

Who are the major players in the Gastrointestinal Over The Counter OTC Drugs market?

What are the key trends in the Gastrointestinal Over The Counter OTC Drugs market?

Major trends in the Gastrointestinal Over The Counter OTC Drugs market include Advancements In OTC Gastrointestinal Drugs For Long-Lasting Acid Relief. For further insights on the Gastrointestinal Over The Counter OTC Drugs market, request a sample here.